MK
Congress trade
Rep. Mike Kelly (R-PA) sold $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
Mike Kelly, U.S. Representative (R-PA), disclosed a sale of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Jun 11, 2026.
The trade happened on May 7, 2026, 35 days before it was made public.
BMY has moved +12.1% since the trade date, from $56.25 to $63.03 (Sep 18, 2026 close).
- Traded
- May 7, 2026
- Disclosed
- Jun 11, 2026
- Filing delay
- 35 days
- Price since
- +12.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (1)
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.